These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16448844)

  • 41. Alphaviruses and their derived vectors as anti-tumor agents.
    Atkins GJ; Smyth JW; Fleeton MN; Galbraith SE; Sheahan BJ
    Curr Cancer Drug Targets; 2004 Nov; 4(7):597-607. PubMed ID: 15578917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current progress of DNA vaccine studies in humans.
    Lu S; Wang S; Grimes-Serrano JM
    Expert Rev Vaccines; 2008 Mar; 7(2):175-91. PubMed ID: 18324888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Delivery of mengovirus-derived RNA replicons into tumoural liver enhances the anti-tumour efficacy of a peripheral peptide-based vaccine.
    Couty JP; Crain AM; Gerbaud S; Labasque M; Marchiol C; Fradelizi D; Boudaly S; Guettier C; Vignuzzi M; van der Werf S; Escriou N; Viguier M
    Cancer Immunol Immunother; 2008 Aug; 57(8):1161-71. PubMed ID: 18256833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Towards progress on DNA vaccines for cancer.
    Lowe DB; Shearer MH; Jumper CA; Kennedy RC
    Cell Mol Life Sci; 2007 Sep; 64(18):2391-403. PubMed ID: 17565444
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.
    Jäger E; Karbach J; Gnjatic S; Neumann A; Bender A; Valmori D; Ayyoub M; Ritter E; Ritter G; Jäger D; Panicali D; Hoffman E; Pan L; Oettgen H; Old LJ; Knuth A
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14453-8. PubMed ID: 16984998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alphavirus-Based Vaccines.
    Lundstrom K
    Methods Mol Biol; 2017; 1581():225-242. PubMed ID: 28374252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modified peptides in anti-cancer vaccines: are we eventually improving anti-tumour immunity?
    Iero M; Filipazzi P; Castelli C; Belli F; Valdagni R; Parmiani G; Patuzzo R; Santinami M; Rivoltini L
    Cancer Immunol Immunother; 2009 Jul; 58(7):1159-67. PubMed ID: 18998128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of a Plasmid DNA-Based Alphavirus Vaccine on Immunization Efficiency.
    Lundstrom K
    Methods Mol Biol; 2021; 2197():33-47. PubMed ID: 32827131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Strategies used for MUC1 immunotherapy: human clinical studies.
    Tang CK; Katsara M; Apostolopoulos V
    Expert Rev Vaccines; 2008 Sep; 7(7):963-75. PubMed ID: 18767946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Delivery and expression of heterologous genes in mammalian cells using self-replicating alphavirus vectors.
    Karlsson GB; Liljeström P
    Methods Mol Biol; 2004; 246():543-57. PubMed ID: 14970615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Woodchuck dendritic cells generated from peripheral blood mononuclear cells and transduced with recombinant human adenovirus serotype 5 induce antigen-specific cellular immune responses.
    Ochoa-Callejero L; Berraondo P; Crettaz J; Olagüe C; Vales A; Ruiz J; Prieto J; Tennant BC; Menne S; González-Aseguinolaza G
    J Med Virol; 2007 May; 79(5):522-9. PubMed ID: 17385694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term protection in hamsters against human parainfluenza virus type 3 following mucosal or combinations of mucosal and systemic immunizations with chimeric alphavirus-based replicon particles.
    Greer CE; Zhou F; Goodsell A; Legg HS; Tang Z; zur Megede J; Uematsu Y; Polo JM; Vajdy M
    Scand J Immunol; 2007 Dec; 66(6):645-53. PubMed ID: 17944814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of viral vectors for the development of vaccines.
    Liniger M; Zuniga A; Naim HY
    Expert Rev Vaccines; 2007 Apr; 6(2):255-66. PubMed ID: 17408374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alphavirus vectors as tools in neuroscience and gene therapy.
    Lundstrom K
    Virus Res; 2016 May; 216():16-25. PubMed ID: 26307195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis.
    Liu B; Ye D; Song X; Zhao X; Yi L; Song J; Zhang Z; Zhao Q
    Vaccine; 2008 Mar; 26(10):1387-96. PubMed ID: 18272260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasmid DNA- and messenger RNA-based anti-cancer vaccination.
    Weide B; Garbe C; Rammensee HG; Pascolo S
    Immunol Lett; 2008 Jan; 115(1):33-42. PubMed ID: 18006079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
    Yu S; Feng X; Shu T; Matano T; Hasegawa M; Wang X; Ma H; Li H; Li Z; Zeng Y
    Vaccine; 2008 Nov; 26(48):6124-31. PubMed ID: 18812199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential of alphavirus vectors in the treatment of advanced solid tumors.
    Kelly BJ; Fleeton MN; Atkins GJ
    Recent Pat Anticancer Drug Discov; 2007 Jun; 2(2):159-66. PubMed ID: 18221060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines.
    Megede JZ; Otten GR; Doe B; Liu H; Srivastava R; Greer C; Legg H; Tang T; Polo JM; Donnelly JJ; Ulmer JB; Barnett SW
    Vaccine; 2006 Apr; 24(15):2755-63. PubMed ID: 16460840
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dendritic cell-based immunotherapy.
    Osada T; Clay TM; Woo CY; Morse MA; Lyerly HK
    Int Rev Immunol; 2006; 25(5-6):377-413. PubMed ID: 17169781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.